Evidence map›Paper›PMID 38144411›Full record

ArticleCanadian liver journal2022

Timing of elimination of hepatitis C virus in Canada's provinces.

Jordan J Feld, Marina B Klein, Yasmine Rahal, Samuel S Lee, Shawn Mohammed, Alexandra King, Daniel Smyth, Yuri Sanchez Gonzalez, Arlene Nugent, Naveed Z Janjua

Abstract read
In one paragraph

Article in Canadian liver journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jordan J FeldToronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-2640-2211
Marina B KleinDepartment of Medicine, McGill University Health Centre, Montreal, Québec, Canada.ORCID https://orcid.org/0000-0002-3063-8430
Yasmine RahalAbbVie Corporation, Saint-Laurent, Québec, Canada.ORCID https://orcid.org/0000-0003-2299-9209
Samuel S LeeCumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0003-4431-272x
Shawn MohammedAbbVie Corporation, Saint-Laurent, Québec, Canada.
Alexandra KingCollege of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.ORCID https://orcid.org/0000-0003-0102-0137
Daniel SmythDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Yuri Sanchez GonzalezAbbVie, Inc., North Chicago, Illinois, United States.ORCID https://orcid.org/0000-0001-7261-1933
Arlene NugentAbbVie, Inc., North Chicago, Illinois, United States.ORCID https://orcid.org/0000-0002-7653-0791
Naveed Z JanjuaBC Centre for Disease Control, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0001-5681-719X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Canadaeliminationhepatitis C virus

Identifiers

PMID38144411
PMCPMC10735197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.